MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Government: International
North America
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Missouri
Industry: Missouri
Arch Oncology, Inc., formerly, Tioma Therapeutics
Organization & Developments: Arch Oncology
Parents
Arch Oncology, Inc., formerly, Tioma Therapeutics
Children
2019: Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer.
Their next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class.
Jumps
*Key People: Arch Oncology
Finance & Acquisitions: Arch Oncology